1. Home
  2. XGN vs CPIX Comparison

XGN vs CPIX Comparison

Compare XGN & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$2.70

Market Cap

64.5M

Sector

Health Care

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$4.08

Market Cap

73.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XGN
CPIX
Founded
2002
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.5M
73.6M
IPO Year
2014
2007

Fundamental Metrics

Financial Performance
Metric
XGN
CPIX
Price
$2.70
$4.08
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$8.86
N/A
AVG Volume (30 Days)
177.8K
1.7M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.70
EPS
N/A
N/A
Revenue
N/A
$42,010,949.00
Revenue This Year
$8.12
N/A
Revenue Next Year
$13.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.75
52 Week Low
$2.59
$1.85
52 Week High
$12.23
$6.27

Technical Indicators

Market Signals
Indicator
XGN
CPIX
Relative Strength Index (RSI) 34.43 70.42
Support Level $2.59 $3.52
Resistance Level $3.29 $4.41
Average True Range (ATR) 0.17 0.35
MACD -0.01 0.11
Stochastic Oscillator 12.05 35.95

Price Performance

Historical Comparison
XGN
CPIX

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: